407 related articles for article (PubMed ID: 10348292)
1. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):619-25. PubMed ID: 10348292
[TBL] [Abstract][Full Text] [Related]
2. A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres.
Maranzano E; De Angelis V; Pergolizzi S; Lupattelli M; Frata P; Spagnesi S; Frisio ML; Mandoliti G; Malinverni G; Trippa F; Fabbietti L; Parisi S; Di Palma A; De Vecchi P; De Renzis C; Giorgetti C; Bergami T; Orecchia R; Portaluri M; Signor M; Di Gennaro D;
Radiother Oncol; 2010 Jan; 94(1):36-41. PubMed ID: 19963296
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced emesis: a problem with many open questions.
Maranzano E
Tumori; 2001; 87(4):213-8. PubMed ID: 11693797
[TBL] [Abstract][Full Text] [Related]
4. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced emesis: effects of ondansetron.
Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy.
Mystakidou K; Kouloulias V; Nikolaou V; Tsilika E; Lymperopoulou G; Balafouta M; Kouvaris I; Kelekis A; Gouliamos A
J BUON; 2010; 15(1):29-35. PubMed ID: 20414924
[TBL] [Abstract][Full Text] [Related]
7. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
8. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
[TBL] [Abstract][Full Text] [Related]
9. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
[TBL] [Abstract][Full Text] [Related]
10. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: a prospective randomized open label study in cancer patients.
Mystakidou K; Katsouda E; Linou A; Parpa E; Kouloulias V; Nikolaou V; Vlahos L
Med Oncol; 2006; 23(2):251-62. PubMed ID: 16720926
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.
Aass N; Håtun DE; Thoresen M; Fosså SD
Radiother Oncol; 1997 Nov; 45(2):125-8. PubMed ID: 9424001
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment.
LeBourgeois JP; McKenna CJ; Coster B; Feyer P; Franzén L; Goedhals L; Marzecki Z; Souhami L; Stewart A; Tønnessen F; Haigh C; Mitchell T; Wilkinson JR; Graham E
Clin Oncol (R Coll Radiol); 1999; 11(5):340-7. PubMed ID: 10591823
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).
Ades S; Halyard M; Wilson K; Ashikaga T; Heimann R; Kumar S; Blackstock W
Support Care Cancer; 2017 May; 25(5):1503-1510. PubMed ID: 28032216
[TBL] [Abstract][Full Text] [Related]
15. [Research on antiemetics: an Italian model of success].
Roila F
Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.
Salvo N; Doble B; Khan L; Amirthevasar G; Dennis K; Pasetka M; Deangelis C; Tsao M; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):408-17. PubMed ID: 21075553
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P
Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy.
Hesketh PJ; Sanz-Altamira P; Bushey J; Hesketh AM
Support Care Cancer; 2012 May; 20(5):1043-7. PubMed ID: 21553313
[TBL] [Abstract][Full Text] [Related]
19. Ondansetron: a review of its use as an antiemetic in children.
Culy CR; Bhana N; Plosker GL
Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189
[TBL] [Abstract][Full Text] [Related]
20. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
